Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001564590-20-019708
Filing Date
2020-04-29
Accepted
2020-04-29 16:10:45
Documents
18
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A amrn-10ka_20191231.htm   iXBRL 10-K/A 1407340
2 EX-31.1 amrn-ex311_6.htm EX-31.1 7682
3 EX-31.2 amrn-ex312_7.htm EX-31.2 7932
4 GRAPHIC g42nhxdeq0lr000001.jpg GRAPHIC 26443
5 GRAPHIC g42nhxdeq0lr000003.jpg GRAPHIC 12067
6 GRAPHIC g42nhxdeq0lr000002.jpg GRAPHIC 20783
  Complete submission text file 0001564590-20-019708.txt   1908507

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA amrn-20191231.xsd EX-101.SCH 6906
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE amrn-20191231_def.xml EX-101.DEF 19238
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE amrn-20191231_lab.xml EX-101.LAB 33847
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amrn-20191231_pre.xml EX-101.PRE 20730
11 EXTRACTED XBRL INSTANCE DOCUMENT amrn-10ka_20191231_htm.xml XML 10178
Mailing Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000
Business Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000 353 1 6699 020
AMARIN CORP PLC\UK (Filer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-21392 | Film No.: 20830381
SIC: 2834 Pharmaceutical Preparations